A phase II study of a human anti-PDGFR alpha monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors

DSpace Repository

A phase II study of a human anti-PDGFR alpha monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors

Author: Wagner, A. J.; Kindler, H.; Gelderblom, H.; Schoffski, P.; Bauer, S.; Hohenberger, P.; Kopp, H. -G.; Lopez-Martin, J. A.; Peeters, M.; Reichardt, P.; Qin, A.; Nippgen, J.; Ilaria, R. L.; Rutkowski, P.
Tübinger Autor(en):
Kopp, Hans-Georg
Published in: Annals of Oncology (2017), Bd. 28, H. 3, S. 541-546
Verlagsangabe: Oxford Univ Press
Language: English
Full text: http://dx.doi.org/10.1093/annonc/mdw659
ISSN: 1569-8041
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)